Our findings are consistent with and extend those of previous studies showing the potential of inflammatory pathways as targets for cardiovascular disease prevention and highlight the need for studies of IL-6 signalling inhibition for the prevention of coronary artery disease. This evidence concerns the gene IL6 and cardiovascular disorder.